ACADIA PHARMACEUTICALS A/S: Financial statements 2019
CVR: 19670694
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
ACADIA PHARMACEUTICALS A/S (CVR 19670694) has filed annual accounts for 2019. In 2019, the company reported a net result of DKK -74,706 compared with DKK -46,546 the year before. Equity in the 2019 report amounted to DKK -509,733.
- Profit/Loss
- DKK -74,706
- Equity
- DKK -509,733
- Total Assets
- DKK 2,538
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | - | -75K | -510K | 0 |
| 2018 | - | - | -47K | -435K | 0 |
| 2017 | - | - | -74K | -388K | 0 |
| 2016 | - | - | -45K | -315K | - |
| 2015 | - | - | -56K | -270K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of November 18, 2019, Martin Choy has joined the board of directors of ACADIA PHARMACEUTICALS A/S.
As of November 18, 2019, Elena Heather Ridloff has joined the board of directors of ACADIA PHARMACEUTICALS A/S.
As of November 18, 2019, Eric Miller has left the board of directors of ACADIA PHARMACEUTICALS A/S.
As of November 17, 2019, Martin Choy has left the board of directors of ACADIA PHARMACEUTICALS A/S.
ACADIA PHARMACEUTICALS A/S has published its annual report for 2018. The net result was DKK -46,546.
As of May 27, 2019, Eric Miller has joined the board of directors of ACADIA PHARMACEUTICALS A/S.
As of May 27, 2019, Austin Kim has joined the board of directors of ACADIA PHARMACEUTICALS A/S.
As of May 27, 2019, Justin Thacker has left the board of directors of ACADIA PHARMACEUTICALS A/S.
As of May 27, 2019, Todd Young has left the board of directors of ACADIA PHARMACEUTICALS A/S.
As of May 27, 2019, Austin Kim is registered as adm. dir. of ACADIA PHARMACEUTICALS A/S.
About ACADIA PHARMACEUTICALS A/S
ACADIA PHARMACEUTICALS A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 1996. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named RECEPTOR TECHNOLOGIES A/S and VICH 4861 A/S. The management consists of Jennifer Jane Rhodes. The board consists of Martin Choy (chair), James Kenji Kihara, Jennifer Jane Rhodes and Peter Francis Chae. The company is owned by Acadia Pharmaceuticals Inc.. The company has 6 employees (2005). In 2025, the company reported a net result of DKK -471,043 compared with DKK -99,365 the year before. Equity in the 2025 report amounted to DKK -1,563,180.